Press Releases

Stay on top of breaking news from Illumina.

Year : 2017
Date Title
04-25-2017 Illumina Reports Financial Results for First Quarter of Fiscal Year 2017
04-11-2017 Illumina to Announce First Quarter 2017 Financial Results on Tuesday, April 25, 2017
04-10-2017 Illumina Launches the VeriSeq™ NIPT Solution in Europe
04-03-2017 Illumina Advances the Use of Genomics in Precision Oncology, Donates Thousands of Somatic Interpretations to CIViC
02-28-2017 Illumina Announces the iHope Network, an Expansion of Its iHope Philanthropic Clinical Whole Genome Sequencing Program
02-21-2017 Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care Conference
02-20-2017 Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina
01-31-2017 Illumina Reports Full Financial Results for Fourth Quarter and Fiscal Year 2016
01-30-2017 Illumina Debuts VeriSeq™ Analysis Software (48 Samples), Optimized Data Analysis for Noninvasive Prenatal Testing
01-27-2017 Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over 30 Years of Leadership Experience in the Healthcare, Telecommunications and Energy Industries
01-17-2017 Illumina to Announce Fourth Quarter and Fiscal Year 2016 Financial Results on Tuesday, January 31, 2017
01-12-2017 Illumina, NRGene Collaborate to Accelerate Development of New Molecular Breeding Tools for Cattle to Support Global Food Production
01-09-2017 Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases
01-09-2017 Illumina Introduces the NovaSeq Series—a New Architecture Designed to Usher in the $100 Genome
01-09-2017 Philips and Illumina join forces to offer integrated genomics solutions for oncology
01-09-2017 IBM and Illumina Partner to Standardize Genomic Data Interpretation
01-05-2017 GRAIL Plans to Raise in Excess of $1B in Series B Funding
01-03-2017 Illumina Taps Garret Hampton, One of the World’s Leading Clinical Genomics Experts, to Head its Clinical Genomics Unit